Explore our blog articles

Dive deeper into the science of Osteoboost, bone health education, and behind-the-scenes updates from our team.

9+ Alternatives to Fosamax for Osteopenia and Osteoporosis (Drugs and Non-Pharmacological Options)

Fosamax can be an effective medication, but the side effects can be worrying. In this guide, we share some alternatives for osteopenia and osteoporosis.

Osteopenia Treatment: Lifestyle Changes, Medication, and a New FDA-Approved Device

Discover osteopenia treatment options, from lifestyle changes and medications to Osteoboost, a newly FDA-approved device.

NPR on Osteoboost and Protecting Your Bones: Sunlight on a Silent Disease

NPR's recent coverage of osteopenia put a spotlight on a disease 40 million adults live with but rarely talk about. Our CEO, Laura Yecies, reflects.

Empowering Women to Take Control of Their Bone Health: Osteoboost Launches Nationwide

Osteoboost, the first FDA-cleared device for osteopenia, is now available nationwide—helping women reduce bone loss with 30 minutes of daily use.

Women Aren’t Ignoring Bone Health. The Healthcare System Is Reaching Them Too Late.

Women care about bone health, but many are reached too late. The State of Bones Report reveals gaps in education, screening, and support during midlife.

Osteoboost State of Bones 2026

The Osteoboost 2026 State of Bones Report surveyed 1,053 U.S. women and 562 community members about their experiences with osteopenia and osteoporosis.

Hormone Replacement Therapy: A Journey from Discovery to Precision Menopause Care

A concise history of hormone replacement therapy, tracing its evolution from early 20th-century breakthroughs to today's evidence-based menopause care...

Funding the Future of Bone Health: Scaling Osteoboost and Expanding Access

With 44M Americans affected by low bone density, Osteoboost secures $8M to expand its FDA-cleared device and redefine early bone health intervention.

Bone Scans Explained (and What Your Results Really Mean)

Learn how DXA, REMS, QCT, TBS, and bone turnover markers help diagnose low bone density, including osteopenia and osteoporosis, and assess fracture risk.

FDA Initiates Removal of “Black Box” Warnings from HRT

Big news today from Washington, D.C.! I was honored to be in the room at the Health and Human Services (HHS) office this morning for a significant development f